Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Mengyuan Dai, Dianbo Liu, Miao Liu, et al.
Cancer Discovery (2020) Vol. 10, Iss. 6, pp. 783-791
Open Access | Times Cited: 1542

Showing 26-50 of 1542 citing articles:

Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, et al.
Cancer Discovery (2020) Vol. 11, Iss. 2, pp. 233-236
Open Access | Times Cited: 205
Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis
Hua Zhang, Han Han, Tianhui He, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 4, pp. 371-380
Open Access | Times Cited: 195
Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis
Yifan Meng, Wanrong Lu, Ensong Guo, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 190
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
David J. Pinato, Alberto Zambelli, Juan Aguilar‐Company, et al.
Cancer Discovery (2020) Vol. 10, Iss. 10, pp. 1465-1474
Open Access | Times Cited: 177
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing
Kimberly E. Hanson, Angela M. Caliendo, Cesar Andres Diaz Arias, et al.
Clinical Infectious Diseases (2021) Vol. 78, Iss. 7, pp. e170-e207
Open Access | Times Cited: 175
Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis
Vignesh Chidambaram, Nyan Lynn Tun, Waqas Haque, et al.
PLoS ONE (2020) Vol. 15, Iss. 11, pp. e0241541-e0241541
Open Access | Times Cited: 169
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 169
COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry
Maria Madeleine Rüthrich, Clemens Gießen-Jung, Stefan Borgmann, et al.
Annals of Hematology (2020) Vol. 100, Iss. 2, pp. 383-393
Open Access | Times Cited: 167
HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America
Carolina Bernabe, Ana I. Velázquez, Coral Olazagasti, et al.
JCO Global Oncology (2022), Iss. 8
Open Access | Times Cited: 160
Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients
Nathalie Lassau, Samy Ammari, Émilie Chouzenoux, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 157
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
Marina Treskova, Laura Haas, Sarah Reda, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 157
Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective
Karlijn de Joode, Daphne W. Dumoulin, Vivian Engelen, et al.
European Journal of Cancer (2020) Vol. 136, pp. 132-139
Open Access | Times Cited: 156
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard, et al.
European Journal of Cancer (2020) Vol. 141, pp. 62-81
Open Access | Times Cited: 154
Risk factors and outcome of COVID-19 in patients with hematological malignancies
José Luís Piñana, Rodrigo Martino, Irene García‐García, et al.
Experimental Hematology and Oncology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 144
The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis
Ghada Elgohary, Shahrukh K. Hashmi, Jan Styczyński, et al.
Hematology/Oncology and Stem Cell Therapy (2020) Vol. 15, Iss. 2, pp. 45-53
Open Access | Times Cited: 143
Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
Dimple Chakravarty, Sujit S. Nair, Nada Hammouda, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 141
Severity of COVID-19 in patients with lung cancer: evidence and challenges
Antonio Passaro, Christine M. Bestvina, Maria Velez Velez, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 3, pp. e002266-e002266
Open Access | Times Cited: 125
Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)
Noha Sharafeldin, Benjamin Bates, Qianqian Song, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 20, pp. 2232-2246
Open Access | Times Cited: 120
A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus
Bhanu Prasad Venkatesulu, Viveksandeep Thoguluva Chandrasekar, Prashanth Girdhar, et al.
JNCI Cancer Spectrum (2021) Vol. 5, Iss. 2
Open Access | Times Cited: 112
Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants
Ludi Yang, Peiwei Chai, Jie Yu, et al.
Cancer Biology and Medicine (2021) Vol. 18, Iss. 1, pp. 298-307
Open Access | Times Cited: 111
Hematological Abnormalities in COVID-19: A Narrative Review
Asma Rahman, Roshan Niloofa, Umesh Jayarajah, et al.
American Journal of Tropical Medicine and Hygiene (2021) Vol. 104, Iss. 4, pp. 1188-1201
Open Access | Times Cited: 109
Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer
Emma G Khoury, Sarah J Nevitt, William Rohde Madsen, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210880-e2210880
Open Access | Times Cited: 78
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 71
Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer
Xiaoyan Yin, Wanqi Zhu, Xiaoyong Tang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 27
Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance
Meredith Leston, Willam Elson, José M. Ordóñez‐Mena, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106110-106110
Open Access | Times Cited: 19

Scroll to top